State Street’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.02M Sell
72,904
-635,905
-90% -$17.6M ﹤0.01% 3312
2025
Q1
$15.7M Sell
708,809
-20,770
-3% -$461K ﹤0.01% 2268
2024
Q4
$14.4M Buy
729,579
+24,867
+4% +$492K ﹤0.01% 2415
2024
Q3
$17.6M Sell
704,712
-713,235
-50% -$17.8M ﹤0.01% 2285
2024
Q2
$26.5M Sell
1,417,947
-470,597
-25% -$8.79M ﹤0.01% 2024
2024
Q1
$37.3M Buy
1,888,544
+342,448
+22% +$6.76M ﹤0.01% 1876
2023
Q4
$27.1M Sell
1,546,096
-215,576
-12% -$3.78M ﹤0.01% 2036
2023
Q3
$30.6M Buy
1,761,672
+109,701
+7% +$1.91M ﹤0.01% 1910
2023
Q2
$23.3M Sell
1,651,971
-145,473
-8% -$2.05M ﹤0.01% 2158
2023
Q1
$19.3M Buy
1,797,444
+307,333
+21% +$3.31M ﹤0.01% 2251
2022
Q4
$22.3M Buy
1,490,111
+878,769
+144% +$13.2M ﹤0.01% 2167
2022
Q3
$7.85M Buy
611,342
+26,511
+5% +$340K ﹤0.01% 2844
2022
Q2
$5.67M Buy
584,831
+17,693
+3% +$171K ﹤0.01% 3045
2022
Q1
$5.64M Sell
567,138
-898,033
-61% -$8.93M ﹤0.01% 3120
2021
Q4
$17.2M Sell
1,465,171
-568,911
-28% -$6.7M ﹤0.01% 2573
2021
Q3
$23.2M Sell
2,034,082
-260,622
-11% -$2.97M ﹤0.01% 2376
2021
Q2
$32M Buy
2,294,704
+879,922
+62% +$12.3M ﹤0.01% 2180
2021
Q1
$26.2M Sell
1,414,782
-163,730
-10% -$3.03M ﹤0.01% 2189
2020
Q4
$27.9M Buy
1,578,512
+1,164,059
+281% +$20.6M ﹤0.01% 2022
2020
Q3
$6.35M Buy
414,453
+90,573
+28% +$1.39M ﹤0.01% 2670
2020
Q2
$8.25M Buy
323,880
+100,650
+45% +$2.56M ﹤0.01% 2528
2020
Q1
$3.46M Sell
223,230
-2,002
-0.9% -$31K ﹤0.01% 2806
2019
Q4
$2.49M Sell
225,232
-4,245
-2% -$46.9K ﹤0.01% 3169
2019
Q3
$1.95M Buy
229,477
+9,282
+4% +$79K ﹤0.01% 3227
2019
Q2
$2.98M Buy
220,195
+93,972
+74% +$1.27M ﹤0.01% 3070
2019
Q1
$2.28M Buy
126,223
+44,499
+54% +$804K ﹤0.01% 3108
2018
Q4
$2.3M Buy
81,724
+17,225
+27% +$484K ﹤0.01% 3062
2018
Q3
$1.65M Buy
+64,499
New +$1.65M ﹤0.01% 3317